Lee Y - Search Results

1

Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome.

Lee Y, Kamada N, Moon JJ. Lee Y, et al. Adv Drug Deliv Rev. 2021 Dec;179:114021. doi: 10.1016/j.addr.2021.114021. Epub 2021 Oct 26. Adv Drug Deliv Rev. 2021. PMID: 34710529 Free PMC article. Review.

2

Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis.

Lee Y, Sugihara K, Gillilland MG 3rd, Jon S, Kamada N, Moon JJ. Lee Y, et al. Nat Mater. 2020 Jan;19(1):118-126. doi: 10.1038/s41563-019-0462-9. Epub 2019 Aug 19. Nat Mater. 2020. PMID: 31427744 Free PMC article.

3

Efficient Lymph Node-Targeted Delivery of Personalized Cancer Vaccines with Reactive Oxygen Species-Inducing Reduced Graphene Oxide Nanosheets.

Xu C, Hong H, Lee Y, Park KS, Sun M, Wang T, Aikins ME, Xu Y, Moon JJ. Xu C, et al. Among authors: lee y. ACS Nano. 2020 Oct 27;14(10):13268-13278. doi: 10.1021/acsnano.0c05062. Epub 2020 Sep 15. ACS Nano. 2020. PMID: 32902245 Free PMC article.

4

Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy.

Lee Y, Shinn J, Xu C, Dobson HE, Neamati N, Moon JJ. Lee Y, et al. Nat Commun. 2023 Aug 8;14(1):4771. doi: 10.1038/s41467-023-40270-5. Nat Commun. 2023. PMID: 37553327 Free PMC article.

5

Antioxidative Hyaluronic Acid-Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy.

Shinn J, Park S, Lee S, Park N, Kim S, Hwang S, Moon JJ, Kwon Y, Lee Y. Shinn J, et al. Among authors: lee y, lee s. ACS Nano. 2024 Feb 13;18(6):4704-4716. doi: 10.1021/acsnano.3c06107. Epub 2024 Jan 30. ACS Nano. 2024. PMID: 38288705

6

Recent progress in development and applications of second near-infrared (NIR-II) nanoprobes.

Shinn J, Lee S, Lee HK, Ahn J, Lee SA, Lee S, Lee Y. Shinn J, et al. Among authors: lee y, lee sa, lee s, lee hk. Arch Pharm Res. 2021 Feb;44(2):165-181. doi: 10.1007/s12272-021-01313-x. Epub 2021 Feb 4. Arch Pharm Res. 2021. PMID: 33538959 Review.

7

Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy.

Lee S, Lee SA, Shinn J, Lee Y. Lee S, et al. Among authors: lee y, lee sa. Int J Nanomedicine. 2024 May 27;19:4893-4906. doi: 10.2147/IJN.S460468. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38828202 Free PMC article.

8

Bilirubin nanoparticles ameliorate allergic lung inflammation in a mouse model of asthma.

Kim DE, Lee Y, Kim M, Lee S, Jon S, Lee SH. Kim DE, et al. Among authors: lee sh, lee y, lee s. Biomaterials. 2017 Sep;140:37-44. doi: 10.1016/j.biomaterials.2017.06.014. Epub 2017 Jun 12. Biomaterials. 2017. PMID: 28624706

9

Preparation and Evaluation of Amino Acid Conjugates of Celecoxib as Prodrugs to Improve the Pharmacokinetic and Therapeutic Properties of Celecoxib.

Lee Y, Kim J, Kim W, Yoon IS, Jung Y. Lee Y, et al. Pharmaceutics. 2020 Oct 30;12(11):1043. doi: 10.3390/pharmaceutics12111043. Pharmaceutics. 2020. PMID: 33143357 Free PMC article.

10

Smart pH-responsive nanomedicines for disease therapy.

Shinn J, Kwon N, Lee SA, Lee Y. Shinn J, et al. Among authors: lee y, lee sa. J Pharm Investig. 2022;52(4):427-441. doi: 10.1007/s40005-022-00573-z. Epub 2022 May 9. J Pharm Investig. 2022. PMID: 35573320 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60,505 results

Search Page

Filters